SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-22-008302
Filing Date
2022-01-27
Accepted
2022-01-27 16:32:15
Documents
1
Group Members
IBEX GP LLCIBEX INVESTMENT HOLDINGS II LLCIBEX INVESTMENT HOLDINGS LLCIBEX ISRAEL FUND LLLPJUSTIN B. BORUS

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm224610d7_sc13ga.htm SC 13G/A 90512
  Complete submission text file 0001104659-22-008302.txt   92305
Mailing Address 260 N. JOSEPHINE STREET SUITE 300 DENVER CO 80206
Business Address 260 N. JOSEPHINE STREET SUITE 300 DENVER CO 80206 303-500-8821
Ibex Investors LLC (Filed by) CIK: 0001531964 (see all company filings)

IRS No.: 331042318 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Subject) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88495 | Film No.: 22563609
SIC: 2834 Pharmaceutical Preparations